Epocrates Cost in 2026: What Epocrates+ Really Costs (and When Free Is Enough)

The short answer: Epocrates has a free tier, and the paid version, Epocrates+, lists at $179.99 per year or $24.99 per month as of July 2026. The free app covers drug monographs, a basic interaction check and a pill identifier; the paid tier adds deeper clinical content, disease information and additional tools. For a lot of clinicians the free version is genuinely enough, so the real question is not the price but whether you need what the paid tier adds.

Epocrates is one of the oldest and most widely used point-of-care drug references, and its pricing is refreshingly simple next to the enterprise references. This piece breaks down what each tier costs, what the money buys, and when it is worth paying versus staying on the free app or reaching for a different kind of tool.

How much does Epocrates cost?

There are two consumer tiers, plus separate arrangements for organizations.

• Epocrates (free). The free app has been the draw for decades: drug monographs, dosing, a multi-drug interaction check and a pill identifier, at no cost. For fast drug lookups on a phone, it does the core job.
• Epocrates+. The paid subscription lists at $179.99 per year or $24.99 per month as of July 2026. It layers deeper clinical and disease content, additional calculators and reference material on top of the free drug tools.
• Teams and enterprise. athenahealth, which owns Epocrates, sells organizational and enterprise arrangements separately, priced by agreement rather than published as a headline number.

Prices change, so confirm the current figure on the Epocrates site before you subscribe. The list rates above are a starting point, not a quote.

Is Epocrates+ worth it?

It depends on whether you use Epocrates as a drug reference or as a broader clinical reference. If your lookups are overwhelmingly "what is the dose, what does it interact with, what does this pill look like," the free app already covers that, and the upgrade buys you content you may rarely open. If you regularly want disease summaries, guideline content and the extra calculators in one place, Epocrates+ consolidates that for a modest annual fee, and $179.99 a year is inexpensive next to the enterprise references.

The honest test is your own usage. Look at what you actually reach Epocrates for over a week. If it is drug facts, the free tier is likely enough. If you keep wishing it went deeper on the clinical side, the paid tier is a fair deal. Either way, it is worth keeping your practice's software subscriptions tracked in one place so a $25-a-month tool that nobody opens does not quietly renew year after year.

How does Epocrates compare to UpToDate on price?

They sit in different price brackets because they do different jobs. Epocrates+ at $179.99 a year is a drug-and-clinical reference built for fast lookups. An individual UpToDate Pro subscription lists at around $579 a year and buys a graded editorial reference written by named physician authors. Epocrates is roughly a third of the price and optimized for speed at the point of care; UpToDate costs more and is built for depth and defensible, graded recommendations. Neither is overpriced for what it is; they are aimed at different needs. If you are weighing the deeper reference, the full breakdown is in what UpToDate really costs.

Is the free version of Epocrates good enough?

For drug lookups, often yes. The free app's monographs, dosing, interaction check and pill identifier cover the everyday questions most clinicians ask a drug reference, which is why the free tier has stayed so popular. Where it stops is depth: it is a reference to consult, not a decision-support layer that watches a specific prescription. It checks the interaction when you ask it to; it does not take a full medication list and surface the interaction, the contraindication and the renal dose adjustment together, unprompted, at the moment you prescribe.

What a drug reference does not do at the point of prescribing

This is the limitation shared by every reference, free or paid, Epocrates or UpToDate: it waits to be asked. To catch a problem with the prescription in front of you, you have to remember to run the interaction check, then the contraindication check, then think about the renal dose, then consider whether a safer alternative exists. Four questions, several lookups, on a schedule that is already behind. The errors that slip through are the checks nobody thought to run.

Prescriber.io is built for that moment rather than the lookup. You enter the drug or scenario once and it checks interactions, flags contraindications and allergy conflicts, surfaces renal and hepatic dose adjustments and suggests guideline-based alternatives, together in one card with the sources cited on each flag. It is decision-support for licensed clinicians, not autonomous prescribing: you review each flag, verify against official sources, and sign. You can try the check at the top of this page, and Epocrates stays perfectly useful next to it for a quick, free drug lookup.

Are there Epocrates discounts or a free trial?

The most important discount is the free tier itself, which is permanent rather than a trial and covers the core drug tools. For Epocrates+, athenahealth periodically runs promotional pricing and trial windows, and students and residents should look for trainee terms before paying the standard rate, the same way you would with any clinical subscription. Institutional and group arrangements are negotiated separately, so if your practice or hospital licenses Epocrates, you may already have paid access without a personal subscription.

Two habits save clinicians money here. First, check whether your employer, residency program or medical library already provides the paid tier before you subscribe personally. Second, review your own usage once a year: a $24.99 monthly plan that renews on autopilot while you only ever open the free features is a quiet, avoidable cost.

Free versus paid: how to decide in one pass

You can settle this quickly. If, over a typical week, you reach for Epocrates almost entirely to answer drug questions, doses, interactions, pill identification, the free app already does that, and Epocrates+ is optional. If you keep hitting the ceiling and wishing it went deeper into disease content, guidelines and calculators, the paid tier consolidates that for a low annual fee and is a reasonable buy. There is no wrong answer, only a fit to how you actually work, and $179.99 a year is small enough that the decision rarely hinges on the price alone.

The bottom line

Epocrates is free at its core, with Epocrates+ at $179.99 a year or $24.99 a month adding deeper clinical content as of July 2026. For most drug lookups the free tier is enough; upgrade only if you genuinely use the broader reference material. And remember that any drug reference answers the question you ask, while the prescribing moment usually asks several at once.